Deborah Kuk, ScM

Assistant Research Biostatistician
Office Phone:
646-735-8076
E-mail:
kukd@mskcc.org
Education:
Johns Hopkins University

Current Research Interests

Ms. Kuk's primary collaboration has been with Dr. Ann Zauber on the National Colonoscopy Study (NCS), a multi-center, randomized controlled trial that investigates colorectal cancer screening with a program of FOBT versus colonoscopy. She has worked on NCS projects that compare the adherence and colonoscopy outcomes of the two screening methods. Ms. Kuk also works with Dr. Mithat Gonen on projects in surgery for the hepatopancreatobiliary, gastric and mixed tumor, and colorectal services. She and Dr. Gonen have also worked on a number of radiology studies that examine the relationship between DCE-MRI parameters with clinical and survival outcomes; and the agreement between CT, FDG and FDHT scans. Other clinical collaborations include the thoracic, radiation oncology, melanoma and sarcoma services.

Publications by Deborah Kuk

M. J. Gollub, D. H. Gultekin, O. Akin, R. K. Do, J. L. Fuqua, M. Gonen, D. Kuk, M. Weiser, L. Saltz and D. Schrag, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. European Radiology. 2012 Apr;22(4): 821-831. 

Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli SL, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, Allison JP, Old LJ, Wolchok JD, Gnjatic S. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16723-8. Epub 2011 Sep 20.

Sarkaria IS, Iyoda A, Roh MS, Sica G, Kuk D, Sima CS, Pietanza MC, Park BJ, Travis WD, Rusch VW. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Ann Thorac Surg. 2011 Oct;92(4):1180-6; discussion 1186-7. Epub 2011 Aug 25.

Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, Dematteo RP, D'Angelica MI, Allen PJ, Jarnagin WR. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol. 2012 Feb;19(2):409-17. Epub 2011 Jun 23.